﻿<!--<!DOCTYPE nitf SYSTEM "nitf-3-4.dtd">-->
<nitf>
  <head>
    <title id="Title">&amp; çâÌæÚUæð´ ·¤è ¥ôÚU Îð¹Ùæ ÁæÚUè ÚU¹ð´ ¥ÍæüÌ ¥ÂÙð ÜÿØ ÂÚU ŠØæÙ ÚU¹ð´Ð ãæÚU Ù ×æÙð´, €UØô´ç·¤ ·¤æ× ·¤ÚUÙð âð ¥æÂ·¤ô ©gðàØ ·¤è Âýæç# ãôÌè ãñ ¥õÚU ÁèßÙ ·¤æ ¹æÜèÂÙ ÎêÚU ãôÌæ ãñÐ ÖÜð ãè ÁèßÙ ×ð´ ç·¤ÌÙè Öè ·¤çÆÙæ§ü €UØô´ Ù ¥æ°, çÁ™ææâæ ¥õÚU ©ˆâæã ÕÙæ° ÚU¹ð´Ð ŠØæÙ ÚU¹ð´, ÜÿØ ã×ðàææ ¥æÂ·Ô¤ Âæâ ãôÌð ãñ´ çÁ‹ãð´ ÂæÙð ·Ô¤ çÜ° ÂýØæâ ¥æÂ ·¤Öè Öè àæéM¤ ·¤ÚU â·¤Ìð ãñ´Ð</title>
    <docdata management-doc-idref="">
      <date.issue id="CreationDate" norm="" />
      <du-key id="rev-ver" generation="1" version="Default" />
      <du-key id="Parent-Version" version="" />
      <identified-content>
        <classifier id="newspro-nitf" value="r2" />
        <classifier id="Newspro-App" value="Epaper" />
        <classifier id="Content-Type" value="Story" />
        <classifier id="storyID" value="" />
        <classifier id="CmsConID" value="" />
        <classifier id="Desk" value="" />
        <classifier id="Source" value="" />
        <classifier id="Edition" value="" />
        <classifier id="Category" value="-1" />
        <classifier id="UserName" value="" />
        <classifier id="PublicationDate" value="20220103" />
        <classifier id="PublicationName" value="Hindustan" />
        <classifier id="IsPublished" value="Y" />
        <classifier id="IsPlaced" value="Y" />
        <classifier id="IsCompleated" value="N" />
        <classifier id="IsProofed" value="N" />
        <classifier id="User" value="" />
        <classifier id="Headline-Count" value="" />
        <classifier id="Slug-Count" value="0" />
        <classifier id="Photo-Count" value="0" />
        <classifier id="Caption-Count" value="0" />
        <classifier id="Word-Count" value="0" />
        <classifier id="Character-Count" value="0" />
        <classifier id="Location" value="" />
        <classifier id="TemplateType" value="1" />
        <classifier id="StoryType" value="Story" />
        <classifier id="Author" value="" />
        <classifier id="UOM" value="mm" />
        <classifier id="IndexPage" value="" />
        <classifier id="box-geometry" value="-7,40,950,284" />
        <classifier id="Epaper-Build" value="Build-No: 2.1.0.9, Dated: 04/12/2021" />
        <classifier id="Application" value="QuarkXpress 8" />
        <classifier id="MachineName" value="TV0254" />
        <classifier id="ProcessingDateTime" value="Mon 03 Jan 2022 07:00:24" />
      </identified-content>
      <urgency id="home-page" ed-urg="0" />
      <urgency id="priority" ed-urg="0" />
      <doc-scope id="scope" value="0" />
    </docdata>
    <pubdata type="print" name="Hindustan" date.publication="20220103T000000+5.30" edition.name="RPAjmCity" edition.area="RPAjmCity" position.section="03012022-RPAjmCity-01-PAGE-03012022_RPAjmCity_01~WS4~" position.sequence="01" ex-ref="03012022-RPAjmCity-01-PAGE-03012022_RPAjmCity_01~WS4~" SectionName="" />
  </head>
  <body>
    <body.head>
      <hedline>
        <hl1 id="kicker" class="1" style="Shoulder" MainHead="false">
          <lang class="3" style="kicker" font="Patrika18" size="12">
</lang>
        </hl1>
        <hl1 id="Headline" class="1" style="Headline" MainHead="true">
          <lang class="3" style="Headline" font="Patrika18" fontStyle="Bold" size="15">Gel prevents hair loss from chemotherapy
</lang>
        </hl1>
        <hl1 id="Subhead" class="1" style="Subhead" MainHead="true">
          <lang class="3" style="Subhead" font="Patrika18" fontStyle="Bold" size="15">
</lang>
        </hl1>
        <hl1 id="Byline" class="1" style="Byline" MainHead="true">
          <lang class="3" style="Byline" font="Patrika18" fontStyle="Bold" size="15">
</lang>
        </hl1>
      </hedline>
      <summary></summary>
      <quotes>
        <quote></quote>
      </quotes>
    </body.head>
    <body.content id="Bodytext">
      <block>
        <media id="1" media-type="image">
          <media-reference id="tn" source-credit="" data-location="1" ImgOrderNum="" source="03012022-RPAjmCity-01-PAGE-03012022_RPAjmCity_01~WS4~_SubGroupImage_720446704_tn.JPG" Units="pixels" width="50" height="50"></media-reference>
          <media-caption id="Caption1" font="">
            <hl2></hl2>
          </media-caption>
          <media-reference id="tn" source-credit="" data-location="2" ImgOrderNum="" source="03012022-RPAjmCity-01-PAGE-03012022_RPAjmCity_01~WS4~_SubGroupImage_720325568_tn.JPG" Units="pixels" width="50" height="50"></media-reference>
          <media-caption id="Caption1" font="">
            <hl2></hl2>
          </media-caption>
          <media-reference id="tn" source-credit="" data-location="3" ImgOrderNum="" source="03012022-RPAjmCity-01-PAGE-03012022_RPAjmCity_01~WS4~_SubGroupImage_720436736_tn.JPG" Units="pixels" width="50" height="50"></media-reference>
          <media-caption id="Caption1" font="">
            <hl2></hl2>
          </media-caption>
          <media-reference id="tn" source-credit="" data-location="4" ImgOrderNum="" source="03012022-RPAjmCity-01-PAGE-03012022_RPAjmCity_01~WS4~_SubGroupImage_715957792_tn.JPG" Units="pixels" width="50" height="50"></media-reference>
          <media-caption id="Caption1" font="">
            <hl2></hl2>
          </media-caption>
          <media-reference id="tn" source-credit="" data-location="5" ImgOrderNum="" source="03P1 StephenHawkings_tn.JPG" Units="pixels" width="50" height="50"></media-reference>
          <media-caption id="Caption1" font="">
            <hl2></hl2>
          </media-caption>
        </media>
      </block>
      <p style=".Bodylaser">
        <lang class="3" style=".Bodylaser" font="Patrika15 Ultra" fontStyle="Bold" size="130">SAN FRANCISCO. Apr 3: A clear gel rubbed on the scalps of rats was able to prevent hair loss from chemotherapy, one of the most distressing side effects of cancer treatment, scientists said Sunday, reports Reuters.
</lang>
      </p>
      <p class=".Bodylaser">
        <lang class="3" style=".Bodylaser" font="Patrika15 Ultra" fontStyle="Bold" size="130">A researcher for developer Glaxo Wellcome Inc. GLXO. L. said the company hopes to start human tests of the gel. which includes a drug known as GW8510. to see if it could help reduce the trauma of chemotherapy.</lang>
      </p>
      <p class=".Bodylaser">
        <lang class="3" style=".Bodylaser" font="Patrika15 Ultra" fontStyle="Bold" size="130">Stephen Davis, the researcher who led the studies, said the gel completely prevented hair loss in half of the rats that subsequently underwent chemotherapy. No side effects were detected and the drug did not Interfere with the cancer-killing effects of the treatment. Davis said.</lang>
      </p>
      <p class=".Bodylaser">
        <lang class="3" style=".Bodylaser" font="Patrika15 Ultra" fontStyle="Bold" size="130">"We noticed a marked protection of the hair, it was Just stunning." Davis told reporters attending the annual meeting of the American Association for</lang>
      </p>
      <p class=".Bodylaser">
        <lang class="3" style=".Bodylaser" font="Patrika15 Ultra" fontStyle="Bold" size="130">Cancer Research.</lang>
      </p>
      <p class=".Bodylaser">
        <lang class="3" style=".Bodylaser" font="Patrika15 Ultra" fontStyle="Bold" size="130">Each year about 1 million Americans are diagnosed with cancer and about 500.000 die from the disease. For those undergoing chemotherapy, hair loss is second only to nausea on the list of most bothersome side effects, scientists said.</lang>
      </p>
      <p class=".Bodylaser">
        <lang class="3" style=".Bodylaser" font="Patrika15 Ultra" fontStyle="Bold" size="130">There is a tremendous unmet need to ... eliminate this additional stress factor among patients already emotionally devastated by a cancer diagnosis.” Davis said.</lang>
      </p>
      <p class=".Bodylaser">
        <lang class="3" style=".Bodylaser" font="Patrika15 Ultra" fontStyle="Bold" size="130">People fear hair loss so much that some even avoid cancer screening that could detect the disease in its early stages when it is easiest to treat, said Dr. William Halt, a cancer specialist who reviewed Glaxo's studies on GW8510.</lang>
      </p>
      <p class=".Bodylaser">
        <lang class="3" style=".Bodylaser" font="Patrika15 Ultra" fontStyle="Bold" size="130">A drug to prevent hair loss would have "an enormous impact not Just on the patient receiving therapy but on the fear it generates." said Halt, who heads the Cancer Institute of New Jersey.</lang>
      </p>
    </body.content>
  </body>
</nitf>